EFFICACY AND SAFETY OF SAXAGLIPTIN、SITAGLIPTIN PLUS METFORMIN FIXED-DOSE COMBINATION AS ADD-ON THERAPY WITH DUAL COMBINATION OF TRADITIONAL ORAL HYPOGLYCEMIC AGENTS IN TYPE 2 DIABETES MELLITUS
- At: 2015 FIP Congress in Düsseldorf (Germany)
- Type: Poster
- By: HU, Chun-Liang (Tainan Municipal Hospital, pharmacy, Tainan, China Taiwan)
- Co-author(s): Chun-Liang Hu
Less data confirm what kind of dipeptidyl peptidase-4 inhibitors/Metformin fixed-dose combination (DPP4I/Met FDC) medicine is more effective and safe when type 2 diabetes mellitus (T2DM) patients need additional medicines to meet glycemic targets.
We retrospectively screened the data of T2DM patients who received Saxagliptin/Metformin 5/1000mg.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.